News
Get the RSS
Category：
Investment
All 
Investment 
Technology 
Others -
Corundum Systems Biology Invests in a Biotech Firm Focused on Skin Health
-
U.S. FDA Grants GrayMatters Health 510(k) Clearance to Market Prism for PTSD
-
Corundum Systems Biology Participates in Concerto Biosciences Series A Financing Round raising $23 million
-
Theranica, a Corundum’s portfolio, raised $45 million in its Series C financing round
-
Initial Closing of Corundum’s Second Israeli VC Fund, and Start of Consulting Service for New Business Development